SOURCE: Industrial Info Resources

Industrial Info Resources

March 03, 2016 07:15 ET

It's About the Money... Top 5 Global Pharma-Bio 2016 Project Investment Soars Past $4 Billion, an Industrial Info News Alert

SUGAR LAND, TX--(Marketwired - Mar 3, 2016) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- While the majority of people bemoan the cost of prescription drugs, few understand the cost of producing those drugs. And this is after having invested billions in developing a drug. The production process is closely monitored, highly regulated and requires a huge capital investment. This fact is illustrated by looking at just the top five manufacturing projects scheduled to kick off this year, which reveals a total investment value (TIV) of $4.1 billion.

Within this article: Details high dollar projects by Novo Nordisk AS (NYSE:NVO), Bristol-Myers Squibb (NYSE:BMS), Teva (NYSE:TEVA) and Siemens Healthcare Diagnostics.

For details, view the entire article by subscribing to Industrial Info's Premium Industry News, or browse other breaking industrial news stories at

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, five offices in North America and 10 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "Contact Us" page.

Contact Information

  • Contact:
    Brian Ford
    (713) 980-9393